FDA Recalls Certain Batches of Levothyroxine Sodium Due to Quality Concerns

The U.S. Food and Drug Administration (FDA) has recalled specific batches of levothyroxine sodium, a medication used to treat hypothyroidism, due to detected quality control issues that could affect the drug's potency or stability. Patients are advised to confirm if their product is part of the recall by checking lot numbers and expiration dates, and to consult a healthcare professional before making any changes to their treatment.